This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Zacks.com featured highlights include Tenet Healthcare, Leidos Holdings, Atmos Energy and Cabot
by Zacks Equity Research
Tenet Healthcare, Leidos Holdings, Atmos Energy and Cabot are part of the Zacks Screen of the Week article.
Here's Why You Should Retain Ensign Group (ENSG) Stock Now
by Zacks Equity Research
Ensign Group (ENSG) remains well-poised for growth on the back of solid segmental contributions, an expanding healthcare portfolio and sound cash reserves.
4 Stocks That Boast Remarkable Interest Coverage Ratio
by Sumit Singh
A company capable of generating earnings well above its interest expense can withstand financial hardship. THC, LDOS, ATO and CBT are sound enough to meet financial obligations.
Zacks.com featured highlights include Amkor Technology, Tenet Healthcare, Leidos and Maximus
by Zacks Equity Research
Amkor Technology, Tenet Healthcare, Leidos and Maximus are part of the Zacks Screen of the Week article.
Community Health (CYH) & Cost Plus Drugs Expand Collaboration
by Zacks Equity Research
Community Health (CYH) is now set to source drugs from the Cost Plus Drugs Marketplace under the new expanded partnership.
4 Stocks Trading Near 52-Week High That Can Climb Further
by Vasundhara Sawalka
Investors target stocks that have been on a bullish run lately. Stocks like AMKR, THC, LDOS and MMS that are seeing price strength have a high chance of carrying the momentum forward.
Zacks Investment Ideas feature highlights: Tenet Healthcare and United Health Services
by Zacks Equity Research
Tenet Healthcare and United Health Services have been highlighted in this Investment Ideas article.
Humana (HUM) Ties Up With PsychArmor for Better Veteran Care
by Zacks Equity Research
Humana's (HUM) subsidiaries team up with PsychArmor to enhance veteran care, offering specialized training at 23 senior primary care centers in Texas, thereby attracting more members of the targeted community to the centers.
Top Health Care Stocks Beating the S&P 500 This Year
by Bryan Hayes
The health care space contains several market leaders that are widely outperforming.
Encompass Health (EHC) Expands in Louisville With New Rehab Unit
by Zacks Equity Research
Encompass Health (EHC) and Baptist Health inaugurate a 40-bed inpatient rehabilitation hospital in Louisville, enhancing regional care and expanding EHC's network to 163 facilities.
Tenet Healthcare (THC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Tenet Healthcare (THC) closed the most recent trading day at $134.93, moving -0.81% from the previous trading session.
Universal Health Services, Inc. (UHS) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Universal Health Services (UHS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks.com featured highlights Abercrombie & Fitch, Tenet Healthcare and PDD Holdings
by Zacks Equity Research
Zacks.com featured highlights Abercrombie & Fitch, Tenet Healthcare and PDD Holdings have been highlighted in this Screen of The Week article.
Tenet Healthcare (THC) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
Tenet Healthcare (THC) reachead $136.03 at the closing of the latest trading day, reflecting a +1.33% change compared to its last close.
Encompass Health (EHC) Gains 30% in a Year: More Room to Run?
by Zacks Equity Research
Encompass Health (EHC) is well-poised for growth on the back of sustained top-line growth, an aging U.S. population, frequent expansion initiatives and strong cash reserves.
Here's Why Tenet Healthcare (THC) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Fast-paced Momentum Stock Tenet (THC) Is Still Trading at a Bargain
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Tenet (THC) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Buy 3 Momentum Anomaly Stocks as Markets Sway on AI Boom
by Supriyo Bose
Abercrombie (ANF), Tenet Healthcare (THC) and PDD Holdings (PDD) are currently witnessing a short-term pullback in price. So, make sure you take full advantage of it.
Universal Health (UHS) Gains 28% in a Year: What Lies Ahead?
by Zacks Equity Research
Universal Health (UHS) remains well-poised for growth on the back of growing patient volumes, acquisitions and a commendable financial position.
Tenet Healthcare (THC) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
In the closing of the recent trading day, Tenet Healthcare (THC) stood at $136.88, denoting a -0.82% change from the preceding trading day.
Here's How Much a $1000 Investment in Tenet Healthcare Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Wall Street Analysts Think Tenet (THC) Is a Good Investment: Is It?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Tenet (THC). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Buy These 4 Stocks With Remarkable Interest Coverage Ratio
by Sumit Singh
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. THC, STRL, ATO and CBT are sound enough to meet financial obligations.
4 Stocks Trading Near 52-Week High With More Upside Potential
by Vasundhara Sawalka
Investors target stocks that have lately been on a bull run. Stocks like LPX, MMS, THC and AMKR are seeing price strength and have a high chance of carrying the momentum forward.
Should Value Investors Buy Tenet Healthcare (THC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.